• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二尖瓣非选择性与选择性经导管缘对缘修复术结局的时间趋势

Temporal Trends in Outcomes of Nonelective Versus Elective Transcatheter Edge-to-Edge Repair of the Mitral Valve.

作者信息

Ashraf Muddasir, Allaqaband Suhail Q, Ammar Khawaja Afzal, Jain Renuka, Harland Daniel R, Zubair Haroon, Sherry Charnai, Bajwa Tanvir

机构信息

Department of Aurora Cardiovascular and Thoracic Services, Aurora St. Luke's Medical Center, Aurora Health Care, Milwaukee, Wisconsin.

Aurora Sinai Medical Center, Aurora Health Care, Milwaukee, Wisconsin.

出版信息

J Soc Cardiovasc Angiogr Interv. 2025 Jul 23;4(8):103785. doi: 10.1016/j.jscai.2025.103785. eCollection 2025 Aug.

DOI:10.1016/j.jscai.2025.103785
PMID:41019883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12462125/
Abstract

BACKGROUND

Data are limited on outcomes of elective vs nonelective mitral transcatheter edge-to-edge repair (M-TEER).

METHODS

Using the National Inpatient Sample, all adult patients who had M-TEER from 2013-2020 were included in the study. Univariate and multivariate linear and logistic regression were used to evaluate outcomes.

RESULTS

Of 43,920 patients who underwent M-TEER, with a mean age (SE) of 77 (0.13) years, 46% were women. Of these, 23% were nonelective, and 77% were elective cases. Whites were more likely to have elective, and African Americans and Hispanics were more likely to have nonelective M-TEER. In-hospital mortality and resource utilization decreased over time in elective cases, but no significant change was seen in nonelective cases. Risk-adjusted odds of in-hospital mortality were higher in nonelective vs elective cases (adjusted odds ratio, 2.85; < .001). Risk-adjusted length of stay was also higher in nonelective vs elective cases (adjusted beta-coefficient, 7.16; < .001). Finally, the risk-adjusted inflation-adjusted cost was also higher in nonelective vs elective cases (adjusted beta-coefficient, 23,673; < .001).

CONCLUSIONS

Nonelective M-TEER is associated with poor outcomes. Hence, these patients should be treated in a timely fashion and should not be deferred if they meet the criteria for M-TEER. Rapid up-titration of guideline-directed medical therapy should be considered in patients with moderate to severe secondary mitral regurgitation to avoid an emergent need for transcatheter edge-to-edge repair and associated poor outcomes.

摘要

背景

关于选择性与非选择性二尖瓣经导管缘对缘修复术(M-TEER)的结果数据有限。

方法

利用全国住院患者样本,纳入2013年至2020年期间接受M-TEER的所有成年患者。采用单因素和多因素线性及逻辑回归来评估结果。

结果

在43920例接受M-TEER的患者中,平均年龄(标准误)为77(0.13)岁,46%为女性。其中,23%为非选择性病例,77%为选择性病例。白人更有可能接受选择性手术,非裔美国人和西班牙裔更有可能接受非选择性M-TEER。选择性病例的住院死亡率和资源利用率随时间下降,但非选择性病例未见显著变化。非选择性病例的住院死亡风险调整比值高于选择性病例(调整后的比值比为2.85;P<0.001)。非选择性病例的风险调整住院时间也高于选择性病例(调整后的β系数为7.16;P<0.001)。最后,非选择性病例的风险调整通胀调整成本也高于选择性病例(调整后的β系数为23673;P<0.001)。

结论

非选择性M-TEER与不良结果相关。因此,这些患者应及时接受治疗,如果符合M-TEER标准,不应推迟治疗。对于中重度继发性二尖瓣反流患者,应考虑迅速加强指南指导的药物治疗,以避免紧急需要经导管缘对缘修复术及相关不良结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b15/12462125/ee3679acea81/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b15/12462125/1c85e2a2d32b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b15/12462125/a7e5b7dc472a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b15/12462125/bd07fa290444/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b15/12462125/c50abef16bc6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b15/12462125/ee3679acea81/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b15/12462125/1c85e2a2d32b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b15/12462125/a7e5b7dc472a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b15/12462125/bd07fa290444/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b15/12462125/c50abef16bc6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b15/12462125/ee3679acea81/gr5.jpg

相似文献

1
Temporal Trends in Outcomes of Nonelective Versus Elective Transcatheter Edge-to-Edge Repair of the Mitral Valve.二尖瓣非选择性与选择性经导管缘对缘修复术结局的时间趋势
J Soc Cardiovasc Angiogr Interv. 2025 Jul 23;4(8):103785. doi: 10.1016/j.jscai.2025.103785. eCollection 2025 Aug.
2
Characteristics of cardiac rehabilitation progress during hospitalization and in-hospital outcomes after mitral transcatheter edge-to-edge repair.经导管二尖瓣缘对缘修复术住院期间心脏康复进程及院内结局的特征
Heart Vessels. 2025 Apr 21. doi: 10.1007/s00380-025-02544-4.
3
Vesicoureteral Reflux膀胱输尿管反流
4
Up-to-date review on concomitant mitral transcatheter edge-to-edge repair and left atrial appendage occlusion.二尖瓣经导管缘对缘修复术与左心耳封堵术同期进行的最新综述
Future Cardiol. 2025 Aug 4:1-9. doi: 10.1080/14796678.2025.2543184.
5
Plasma volume status predicting clinical outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair.预测经导管二尖瓣缘对缘修复术患者临床结局的血浆容量状态
ESC Heart Fail. 2025 Apr 17. doi: 10.1002/ehf2.15295.
6
Mid Forehead Brow Lift额中眉提升术
7
Quality of Life After Mitral Transcatheter Edge-to-Edge Repair According to Baseline Tricuspid Regurgitation.根据基线三尖瓣反流情况评估经导管二尖瓣缘对缘修复术后的生活质量
Struct Heart. 2025 Jan 2;9(6):100408. doi: 10.1016/j.shj.2024.100408. eCollection 2025 Jun.
8
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
9
Temporal trends and procedural safety of mitral valve transcatheter edge to edge repair in patients with previous CABG.既往接受冠状动脉旁路移植术(CABG)患者行经导管二尖瓣缘对缘修复术的时间趋势和手术安全性
Future Cardiol. 2025 Jan;21(1):15-22. doi: 10.1080/14796678.2024.2442238. Epub 2024 Dec 23.
10
Transcatheter management of left-sided valvular heart disease following heart transplantation.心脏移植后左侧瓣膜性心脏病的经导管治疗
Eur J Cardiothorac Surg. 2025 Jun 3;67(6). doi: 10.1093/ejcts/ezaf191.

本文引用的文献

1
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation.经导管二尖瓣修复术治疗中重度二尖瓣反流合并心力衰竭。
N Engl J Med. 2024 Nov 14;391(19):1799-1809. doi: 10.1056/NEJMoa2314328. Epub 2024 Aug 31.
2
Racial Disparities in Access to High-Volume Mitral Valve Transcatheter Edge-to-Edge Repair Centers.获得高容量二尖瓣经导管缘对缘修复中心的种族差异。
J Soc Cardiovasc Angiogr Interv. 2022 Jul 13;1(5):100398. doi: 10.1016/j.jscai.2022.100398. eCollection 2022 Sep-Oct.
3
Comparison of Transcatheter Edge-to-Edge Mitral Valve Repair for Primary Mitral Regurgitation Outcomes to Hospital Volumes of Surgical Mitral Valve Repair.
经导管缘对缘二尖瓣修复术治疗原发性二尖瓣反流的效果与外科二尖瓣修复术的医院手术量比较。
Circ Cardiovasc Interv. 2024 Apr;17(4):e013581. doi: 10.1161/CIRCINTERVENTIONS.123.013581. Epub 2024 Mar 4.
4
Is the outcome of elective vs non-elective patients undergoing transcatheter aortic valve implantation different? Results of a single-centre, observational assessment of outcomes at a large university clinic.择期与非择期行经导管主动脉瓣置换术患者的结局是否不同?来自一家大型大学诊所的单中心观察性结局评估结果。
BMC Cardiovasc Disord. 2023 Jun 10;23(1):295. doi: 10.1186/s12872-023-03317-5.
5
Racial disparities in characteristics and outcomes of patients undergoing mitral transcatheter edge-to-edge repair.接受二尖瓣经导管缘对缘修复术患者的特征和结局的种族差异。
Front Cardiovasc Med. 2023 Mar 2;10:1111714. doi: 10.3389/fcvm.2023.1111714. eCollection 2023.
6
Procedural, Short-Term, and Intermediate-Term Outcomes in Propensity-Matched Patients With Severe Mitral Valve Regurgitation Undergoing Urgent Versus Elective MitraClip Percutaneous Mitral Valve Repair.在紧急和择期经皮二尖瓣夹合修复术治疗严重二尖瓣反流的患者中,倾向匹配患者的手术、短期和中期结果。
J Cardiothorac Vasc Anesth. 2022 May;36(5):1268-1275. doi: 10.1053/j.jvca.2021.12.008. Epub 2021 Dec 16.
7
Transcatheter mitral valve repair may increase eligibility for heart transplant listing in patients with end-stage heart failure and severe secondary mitral regurgitation.经导管二尖瓣修复术可能会增加晚期心力衰竭和严重二尖瓣反流患者进行心脏移植的资格。
Int J Cardiol. 2021 Sep 1;338:72-78. doi: 10.1016/j.ijcard.2021.06.031. Epub 2021 Jun 19.
8
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry.经导管二尖瓣夹合术治疗继发性二尖瓣反流作为心脏移植桥接治疗:国际 MitraBridge 注册研究的 1 年结果。
J Heart Lung Transplant. 2020 Dec;39(12):1353-1362. doi: 10.1016/j.healun.2020.09.005. Epub 2020 Sep 17.
9
Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.经导管二尖瓣修复术与心力衰竭并二尖瓣反流患者药物治疗的成本效益比较:来自 COAPT 试验的结果。
Circulation. 2019 Dec 3;140(23):1881-1891. doi: 10.1161/CIRCULATIONAHA.119.043275. Epub 2019 Sep 29.
10
Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome.社区孤立性二尖瓣反流的病因和机制:临床背景和结局。
Eur Heart J. 2019 Jul 14;40(27):2194-2202. doi: 10.1093/eurheartj/ehz314.